Abstract
Pregnancy in obese women can have serious consequences, which must be considered by clinicians and women when deciding upon the optimal method of contraception. There is increased risk of eclampsia, preterm birth, cesarean delivery, postpartum hemorrhage, thromboembolic events, and risk of maternal death during pregnancy and in the postpartum period. There are also increased cardiovascular, metabolic, and neoplastic risks throughout individual’s life. There are also changes in pharmacokinetics of steroid hormones used in hormonal contraception. Therefore obese women need highly effective contraceptives with a low-risk profile regarding cardiovascular, metabolic diseases, and cancers. Long-acting reversible contraceptives, including copper intrauterine devices, levonorgestrel-containing intrauterine systems, and progestogens-based implants, are very appropriate to meet the needs of obese women. The individual decision-making should take account of medical and psychosocial profile of women.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
